Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Appointed director
CC transcript
CYBERONICS INC (CYBX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/19/2015 8-K Quarterly results
10/16/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/22/2015 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "CYBERONICS STOCKHOLDERS OVERWHELMINGLY APPROVE MERGER WITH SORIN"
09/10/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "SORIN AND CYBERONICS ANNOUNCE APPOINTMENT OF LIVANOVA'S CHIEF FINANCIAL OFFICER"
09/09/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "No Further Legal Action By Italian State's Attorney To Enjoin The Combination Of Sorin And Cyberonics Sorin and Cyberonics announce termination of Italian creditor rights objection process MILAN and HOUSTON, Sept. 8, 2015 /PRNewswire/ — Sorin S.p.A., , a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics, Inc. , a medical device company with core expertise in neuromodulation, today announced that no appeal of the decision of the Civil Court of Milan at first instance to refuse to enjoin the planned combination of Sorin and Cyberonics under a newly formed holding company, LivaNova PLC has been filed within the prescribed deadline. With the termination of the creditor rights process, Sorin has satisfied an additional condition to the comple..."
08/20/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "CYBERONICS AND SORIN PROVIDE MERGER UPDATE Cyberonics Sets September 22, 2015 Special Stockholder Meeting to Vote on Proposed Merger Houston, TX, and Milan, Italy, August 20, 2015 — Cyberonics, Inc. and Sorin S.p.A. today announced an update on various matters relating to their pending business combination . The companies announced that the registration statement on Form S-4 for LivaNova, PLC filed on April 20, 2015 and amended on June 12, 2015, July 13, 2015 and August 17, 2015, was declared effective by the Securities and Exchange Commission on August 19, 2015, thus paving the way for convening the special meeting of Cyberonics stockholders to consider and vote on the Transaction. Cyberonics announced that it has set a date for a special meeting of its stockholders to consider and vote o..."
08/20/2015 8-K Quarterly results
Docs: "CYBERONICS REPORTS FISCAL 2016 FIRST QUARTER RESULTS Record Net Sales of $81 million Record U.S. Net Sales of $68 million Continued International Growth Strong adoption of AspireSR® Generator"
06/04/2015 8-K Quarterly results
Docs: "CYBERONICS REPORTS QUARTER AND ANNUAL RESULTS Fiscal 2015 Net Sales of $292 million Record Adjusted Operating Income Continued Strong International Results AspireSR® U.S. Regulatory Approval"
04/14/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "SORIN-CYBERONICS MERGER RECEIVES U.S. ANTITRUST APPROVAL"
03/23/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Transaction Agreement, by and among Cyberonics, Inc., Sorin S.p.A., Sand Holdco Limited and Cypher Merger Sub, Inc"
02/26/2015 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Letter of Intent, by and among Cyberonics, Inc., Sorin S.p.A., Sand Holdco Limited and Cypher Merger Sub, Inc",
"Support Agreement, by and among Cyberonics, Inc., Mittel S.p.A., Equinox Two S.c.a., Tower 6 S. à r.l., Ghea S.r.l., Bios S.p.A. and Tower 6Bis S.àr.l",
"Cyberonics And Sorin Group To Merge, Creating A New Premier Global Medical Technology Company Diverse product portfolio and scale across geographies to drive shareholder value Focused innovation platform to exploit market opportunities and accelerate product development in heart failure, sleep apnea and percutaneous mitral valve to improve patient outcomes All-stock transaction resulting in pro forma combined equity value of $2.7 billion Transaction expected to enhance revenue growth, drive cash flow generation and be accretive to cash EPS for all shareholders from 2016"
02/26/2015 8-K Quarterly results
Docs: "CYBERONICS REPORTS FISCAL 2015 THIRD QUARTER RESULTS CE Mark approval of VITARIA™ generator for CHF U.S. revenue growth of 9% to $58m Continued strong earnings growth Conference call time changed to 7:00AM / 8:00AM"
01/29/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "†"
01/07/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Form of Employment Agreement effective January 1, 2015 (as to Messrs. Browne and Wise)",
"Employment Agreement of Rohan J. Hoare effective January 1, 2015"
12/19/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/20/2014 8-K Quarterly results
Docs: "CYBERONICS, INC. PRESS RELEASE DATED NOVEMBER 20, 2014"
09/18/2014 8-K Submission of Matters to a Vote of Security Holders
08/21/2014 8-K Quarterly results
Docs: "CYBERONICS REPORTS FISCAL 2015 FIRST QUARTER RESULTS Year-on-year sales increase for the 25th consecutive quarter Continued strong earnings growth Achievement of important product development milestones"
06/04/2014 8-K Quarterly results
Docs: "CYBERONICS REPORTS RECORD QUARTER AND ANNUAL RESULTS AND PROVIDES FISCAL 2015 GUIDANCE Fiscal 2014 Net Sales of $282 million, an 11% Increase Record Quarterly Net Sales and Operating Income Continued Strong International Results"
04/28/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/20/2014 8-K Quarterly results
Docs: "CYBERONICS REPORTS FISCAL 2014 THIRD QUARTER RESULTS Net Product Sales of $68.2 million, 9.4% Increase Continued Strong International Results AspireSR™ Generator approved for sale in Europe"
11/21/2013 8-K Quarterly results
Docs: "CYBERONICS REPORTS RECORD FISCAL 2014 SECOND QUARTER RESULTS Net Product Sales of $70.1 million, 12% Increase Led by Record U.S. Results Submission of AspireSR™ Generator for CE Mark Approval in Europe"
09/20/2013 8-K Submission of Matters to a Vote of Security Holders
09/12/2013 8-K Form 8-K - Current report
08/22/2013 8-K Quarterly results
Docs: "CYBERONICS REPORTS FISCAL 2014 FIRST QUARTER RESULTS Net Product Sales of $67.4 million, 12.4% Increase Strong International Sales led by Europe"
08/01/2013 8-K Form 8-K - Current report
06/05/2013 8-K Form 8-K - Current report
05/28/2013 8-K Form 8-K - Current report
02/22/2013 8-K Form 8-K - Current report
11/16/2012 8-K Quarterly results
Docs: "CYBERONICS REPORTS FISCAL 2013 SECOND QUARTER RESULTS"
09/20/2012 8-K Submission of Matters to a Vote of Security Holders
09/11/2012 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Warrant Amendment Agreement, between Cyberonics, Inc. and Merrill Lynch International, through its agent Merrill Lynch, Pierce, Fenner & Smith Incorporated"
08/28/2012 8-K Form 8-K - Current report
06/06/2012 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy